Another study by De Fonseka et al. on VTE events in IBD patients supports an antithrombotic property of TNF-α inhibitors with an OR of 0.20 (p = 0.049), as well as systemic corticosteroid prothrombotic action with an OR of 4.62 (p = 0.0004) [79]. Here, TNF is linked to inflammatory bowel disease.